On Friday, Aclaris Therapeutics Inc (NASDAQ: ACRS) was -4.32% drop from the session before settling in for the closing price of $3.01. A 52-week range for ACRS has been $1.05 – $3.47.
Healthcare Sector giant saw their annual sales surged by 15.24% over the last five years. When this article was written, the company’s average yearly earnings per share was at 68.84%. With a float of $92.54 million, this company’s outstanding shares have now reached $108.34 million.
Aclaris Therapeutics Inc (ACRS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aclaris Therapeutics Inc stocks. The insider ownership of Aclaris Therapeutics Inc is 14.58%, while institutional ownership is 67.28%.
Aclaris Therapeutics Inc (ACRS) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.01 earnings per share (EPS) during the time that was less than consensus figure (set at -0.38) by -0.64. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.01% during the next five years compared to 15.24% growth over the previous five years of trading.
Aclaris Therapeutics Inc (NASDAQ: ACRS) Trading Performance Indicators
You can see what Aclaris Therapeutics Inc (ACRS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Aclaris Therapeutics Inc (ACRS)
As of the previous 9 days, the stock’s Stochastic %D was 41.48%.
During the past 100 days, Aclaris Therapeutics Inc’s (ACRS) raw stochastic average was set at 68.60%, which indicates a significant increase from 15.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.71, while its 200-day Moving Average is $1.87. Now, the first resistance to watch is $3.01. This is followed by the second major resistance level at $3.14. The third major resistance level sits at $3.23. If the price goes on to break the first support level at $2.78, it is likely to go to the next support level at $2.69. Should the price break the second support level, the third support level stands at $2.56.
Aclaris Therapeutics Inc (NASDAQ: ACRS) Key Stats
There are 108,345K outstanding shares of the company, which has a market capitalization of 312.03 million. As of now, sales total 18,720 K while income totals -132,070 K. Its latest quarter income was 3,300 K while its last quarter net income were -14,610 K.
